Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials
Publication in refereed journal

替代計量分析
.

其它資訊
摘要Background: Acetylcholinesterase inhibitor (AChEI) and memantine are recognized drug treatments with limited clinical efficacy. Combination therapy for patients with Alzheimer disease (AD) was suggested, but the additional benefit of combination therapy is still controversial.
著者Tsoi KKF, Chan JYC, Leung NWY, Hirai HW, Wong SYS, Kwok TCY
期刊名稱Journal of the American Medical Directors Association
出版年份2016
月份9
日期1
卷號17
期次9
出版社ELSEVIER SCIENCE INC
頁次863.e1 - 863.e8
國際標準期刊號1525-8610
語言英式英語
關鍵詞AChEI; Alzheimer disease; Combination; memantine; monotherapy
Web of Science 學科類別Geriatrics & Gerontology

上次更新時間 2020-16-09 於 02:49